- Home
- VTOL vs KURA Comparison
VTOL vs KURA Comparison
Compare VTOL & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTOL | KURA |
|---|---|---|
| Founded | 1948 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2011 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VTOL | KURA |
|---|---|---|
| Price | $46.14 | $11.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $58.00 | $25.56 |
| AVG Volume (30 Days) | 182.6K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | ★ 34.58 | N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $1,490,512,000.00 | $67,482,000.00 |
| Revenue This Year | $11.64 | $28.28 |
| Revenue Next Year | $5.59 | $106.37 |
| P/E Ratio | $40.97 | ★ N/A |
| Revenue Growth | 5.30 | ★ 25.24 |
| 52 Week Low | $35.03 | $7.36 |
| 52 Week High | $50.38 | $12.90 |
Technical Indicators
Market Signals| Indicator | VTOL | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 59.25 | 70.90 |
| Support Level | $46.31 | $7.71 |
| Resistance Level | $46.92 | $12.34 |
| Average True Range (ATR) | 1.41 | 0.54 |
| MACD | -0.00 | 0.36 |
| Stochastic Oscillator | 84.21 | 85.87 |
Price Performance
Historical ComparisonAbout VTOL Bristow Group Inc.
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers are in the UK, Norway, the USA, Nigeria, and Others. The offshore energy customers use services to transport personnel to, from and between offshore energy installations. The majority of revenue is generated from Offshore Energy Services.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.